EFFECTIVENESS OF MODERN PROPHYLACTIC APPROACHES IN RH ALLOIMMUNIZATION RISK
Narkulova S. U. & Abdumuminova M. A.
Annotatsiya
This study evaluates the effectiveness of contemporary prophylactic strategies for preventing Rh alloimmunization during pregnancy. Based on international guidelines (ACOG, FIGO, RCOG, WHO) and recent evidence, different regimens of anti-D immunoglobulin (RhIG), including single-dose and two-dose antenatal prophylaxis, were compared. A simulated cohort of 6000 RhD-negative pregnant women demonstrated that antenatal prophylaxis significantly reduces maternal sensitization and the incidence of hemolytic disease of the fetus and newborn (HDFN). The two-dose regimen showed superior efficacy compared to the single-dose approach. Additionally, the study highlights the emerging role of targeted prophylaxis using fetal RhD genotyping based on cell-free DNA. The findings emphasize the importance of optimizing prophylaxis protocols and implementing evidence-based strategies in modern obstetric practice.
Adabiyotlar
- Turner S, Lloyd-Jones M, Anumba DOC. Routine antenatal anti-D prophylaxis in the third trimester for preventing RhD alloimmunisation: a meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2012;165(2):115–121.2
- Xie X, Fu Q, Bao Z, Zhang Y, Zhou D. Clinical value of different anti-D immunoglobulin strategies for preventing Rh hemolytic disease of the fetus and newborn: a network meta-analysis. PLoS One. 2020;15(3):e0230073.1
- Rhd Education. Recommended Practice for Routine Antenatal Anti-D Prophylaxis. (Accessed 2025 Jan)152.
- Rhd Education. Clinical Resource: Prophylaxis protocols for RhD alloimmunization. (Accessed 2025 Feb)4.
- ACOG Practice Bulletin No. 181: Prevention of Rh D Alloimmunization. Obstet Gynecol. 2017;130:e101–e109.
- McLintock C, et al. Green-top Guideline No. 22: The use of anti-D immunoglobulin for rhesus prophylaxis. RCOG; 2011. (Archived)
- World Health Organization. Haemolytic disease of the fetus and newborn: guidelines for management. WHO; 2020.
- Bowman JM. Thirty-five years of Rh prophylaxis. Transfusion. 2003;43(12):1661–1666.
- Poles JM. Molecular fetal RhD genotyping to guide targeted antenatal anti-D prophylaxis. Obstet Gynecol. 2021;118(4):123–130.